Agnieszka Barbach, M.Sc. – “Znaczenie Hsp90 w przeciwnowotworowej aktywności kalcytriolu i takalcytolu wobec komórek raka jelita grubego”

We invite you to the IITD seminar, which will take place on 30 April 2026 (Thursday) at 9:00 a.m. in the Institute auditorium. During the seminar, Agnieszka Barbach, M.Sc. (Laboratory of Experimental Anticancer Therapy) will deliver a lecture entitled: “Znaczenie Hsp90 w przeciwnowotworowej aktywności kalcytriolu i takalcytolu wobec komórek raka jelita grubego”

Assistant Professor (Junior researcher) AD11/W3/04/2026_ENG

Assistant Professor (Junior researcher) Project: “Personalized antibody-drug conjugates activated by matrix metalloproteinases for solid tumors”, acronym: PACMAN, Virtual Research Institute (WIB); managing entity: Łukasiewicz Research Network – PORT; project leader: Marcin Poręba, PhD, DSc, Prof. of WUST. The PACMAN project aims to develop a new class of antibody–drug conjugates (ADCs) that do Czytaj więcej…

Assistant Professor (Junior researcher) AD9/W3/04/2026_ENG

Assistant Professor (Junior researcher) Faculty/Unit/Organizational unit: Department of Biological Chemistry and Bioimaging, Faculty of Chemistry, Wrocław University of Science and Technology Project: “Personalized antibody-drug conjugates activated by matrix metalloproteinases for solid tumors”, acronym: PACMAN, Virtual Research Institute (WIB); managing entity: Łukasiewicz Research Network – PORT; project leader: Marcin Poręba, PhD, DSc, Prof. Czytaj więcej…